Dyne Therapeutics, Inc.(DYN) said that it has priced an upsized underwritten public offering of 18.980 million shares at $18.44 per share for the gross proceeds of $350 million. The offering is anticipated to be closed on or about December 11.
In addition, the company has granted the underwriters a 30-day option to purchase up to an additional 2.847 million shares at $18.44 per share.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.